Atopic conjunctivitis
MONDO:0005642Conjunctivitis due to hypersensitivity to various allergens.
Also known as: Atopic conjunctivitis, allergic conjunctivitis, allergic conjunctivitis (disease), allergic form of conjunctivitis (disease)
26 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Needle-Free epinephrine film could transform emergency allergy care for kids
Disease control CompletedThis study tests a new dissolving film called DESF that delivers epinephrine under the tongue. It is designed for children ages 7 to 17 who weigh at least 30 kg and have a history of allergic reactions that put them at high risk for severe episodes like anaphylaxis. The goal is t…
Phase: PHASE1 • Sponsor: Aquestive Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Eye insert could ease allergy symptoms for contact lens wearers
Symptom relief CompletedThis early study tested a dexamethasone eye insert placed by a doctor against a standard steroid gel for treating allergy and dry eye symptoms in 36 people with keratoconus who wear gas permeable contact lenses. The goal was to see if the insert improves signs like eyelid bumps a…
Phase: EARLY_PHASE1 • Sponsor: Illinois College of Optometry • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Which eye drop stings less? small study pits flarex against lotemax SM
Symptom relief CompletedThis study tested how comfortable two prescription steroid eye drops feel right after use. Forty adults with eye inflammation or dry eye received one drop of Flarex in one eye and one drop of Lotemax SM in the other. They rated comfort and vision impact at 30 seconds, 5 minutes, …
Phase: PHASE4 • Sponsor: Harrow Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New eye drops zap allergy itch in just minutes
Symptom relief CompletedThis study tested an eye drop called reproxalap in 131 adults with moderate-to-severe seasonal eye allergies. Participants were exposed to ragweed pollen in a special chamber to trigger symptoms. The eye drop was compared to a placebo (no active ingredient) to see if it reduced i…
Phase: PHASE3 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New drug could soothe cat allergy eyes
Symptom relief CompletedThis study tested two experimental drugs, REGN1908 and REGN1909, mixed together to reduce eye allergy signs and symptoms in people with cat allergies. The goal was to see how safe and effective the drug is compared to a placebo. The study included 64 participants with a history o…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New drug cocktail aims to stop itchy eyes from birch pollen
Symptom relief CompletedThis study tested two experimental drugs, REGN5713 and REGN5715, given together to reduce eye allergy symptoms caused by birch pollen. Fifty-four adults with a history of moderate to severe birch pollen allergy received the drug combo or a placebo. The main goal was to see if the…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can ectoin sprays and drops soothe hay fever? new study investigates
Symptom relief CompletedThis study tested whether Ectoin allergy nasal spray and eye drops can relieve symptoms of hay fever (runny nose, sneezing, itchy eyes) better than a placebo. 46 adults with ragweed allergies were exposed to pollen in a special chamber. Researchers measured symptom scores and nas…
Phase: NA • Sponsor: Bitop AG • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New eye drop shows promise for allergy itch
Symptom relief CompletedThis phase 2 trial tested whether VSJ-110 eye drops can reduce itching and redness caused by allergic conjunctivitis (eye allergies). 47 adults received either the active eye drop or a placebo, then were exposed to an allergen. The study measured how much their eyes itched and re…
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jun 26, 2026 15:34 UTC